Prosperity Capital Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.45M | Buy |
29,371
+7,784
| +36% | +$1.44M | 0.51% | 32 |
|
2025
Q1 | $4.45M | Buy |
21,587
+585
| +3% | +$121K | 0.35% | 54 |
|
2024
Q4 | $3.73M | Sell |
21,002
-292
| -1% | -$51.9K | 0.3% | 64 |
|
2024
Q3 | $4.21M | Buy |
21,294
+14,628
| +219% | +$2.89M | 0.36% | 55 |
|
2024
Q2 | $1.14M | Sell |
6,666
-14,160
| -68% | -$2.43M | 0.13% | 123 |
|
2024
Q1 | $3.79M | Buy |
20,826
+2,515
| +14% | +$458K | 0.45% | 39 |
|
2023
Q4 | $2.84M | Buy |
18,311
+78
| +0.4% | +$12.1K | 0.31% | 49 |
|
2023
Q3 | $2.72M | Buy |
18,233
+571
| +3% | +$85.1K | 0.36% | 49 |
|
2023
Q2 | $2.38M | Buy |
17,662
+895
| +5% | +$121K | 0.33% | 55 |
|
2023
Q1 | $2.67M | Buy |
16,767
+67
| +0.4% | +$10.7K | 0.41% | 48 |
|
2022
Q4 | $2.7M | Buy |
+16,700
| New | +$2.7M | 0.83% | 18 |
|